Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02684461 |
| Title | Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | UNC Lineberger Comprehensive Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UNC Lineberger Comprehsive Cancer Center | Chapel Hill | North Carolina | 27599 | United States | Details | |
| Rex Cancer Center | Raleigh | North Carolina | 27607 | United States | Details | |
| Rex Cancer Center of Wakefield | Raleigh | North Carolina | 27614 | United States | Details | |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | United States | Details | |
| Inova Schar Cancer Institute | Fairfax | Virginia | 22031 | United States | Details |